Carroll Financial Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $44K | Sell |
96
-5
| -5% | -$2.29K | ﹤0.01% | 757 |
|
|
2021
Q3 | $42K | Buy |
101
+3
| +3% | +$1.25K | ﹤0.01% | 794 |
|
|
2021
Q2 | $35K | Buy |
98
+6
| +7% | +$2.14K | ﹤0.01% | 920 |
|
|
2021
Q1 | $25K | Hold |
92
| – | – | ﹤0.01% | 961 |
|
|
2020
Q4 | $26K | Hold |
92
| – | – | ﹤0.01% | 860 |
|
|
2020
Q3 | $25K | Sell |
92
-261
| -74% | -$70.9K | ﹤0.01% | 811 |
|
|
2020
Q2 | $80K | Buy |
353
+246
| +230% | +$55.8K | 0.01% | 528 |
|
|
2020
Q1 | $16K | Hold |
107
| – | – | ﹤0.01% | 837 |
|
|
2019
Q4 | $16K | Sell |
107
-26
| -20% | -$3.89K | ﹤0.01% | 935 |
|
|
2019
Q3 | $18K | Hold |
133
| – | – | ﹤0.01% | 861 |
|
|
2019
Q2 | $16K | Buy |
133
+28
| +27% | +$3.37K | ﹤0.01% | 888 |
|
|
2019
Q1 | $11K | Hold |
105
| – | – | ﹤0.01% | 928 |
|
|
2018
Q4 | $10K | Sell |
105
-5
| -5% | -$476 | ﹤0.01% | 866 |
|
|
2018
Q3 | $13K | Buy |
110
+33
| +43% | +$3.9K | ﹤0.01% | 835 |
|
|
2018
Q2 | $7K | Hold |
77
| – | – | ﹤0.01% | 965 |
|
|
2018
Q1 | $6K | Hold |
77
| – | – | ﹤0.01% | 993 |
|
|
2017
Q4 | $7K | Hold |
77
| – | – | ﹤0.01% | 938 |
|
|
2017
Q3 | $7K | Hold |
77
| – | – | ﹤0.01% | 916 |
|
|
2017
Q2 | $7K | Buy |
+77
| New | +$7K | ﹤0.01% | 919 |
|